0
0
12/8/23 at 11:00am
Organization
Cancertherapyadvisor.com
33 words
0
Comments
Patients who have been treated for BRCA1/2-mutant breast cancer do not appear to have adverse pregnancy outcomes.
You are the first to view
https://www.cancertherapyadvisor.com/home/news/conference-coverage/san-antonio-breast-cancer-symposium-sabcs/sabcs-2023/pregnancy-breast-cancer-not-contraindicated-brca-carriers/
Create an account
or login to join the discussion